Cargando…

The Metastatic Bone Marrow Niche in Neuroblastoma: Altered Phenotype and Function of Mesenchymal Stromal Cells

SIMPLE SUMMARY: Patients with metastatic neuroblastoma are at risk for relapse after conventional therapy. It is believed that residual neuroblastoma cells in the bone marrow (BM) are responsible for this process after becoming resistant to chemotherapy. Studies in various tumor types suggest that c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hochheuser, Caroline, van Zogchel, Lieke M. J., Kleijer, Marion, Kuijk, Carlijn, Tol, Simon, van der Schoot, C. Ellen, Voermans, Carlijn, Tytgat, Godelieve A. M., Timmerman, Ilse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692745/ https://www.ncbi.nlm.nih.gov/pubmed/33147765 http://dx.doi.org/10.3390/cancers12113231

Ejemplares similares

The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery
por: Hochheuser, Caroline, et al.
Publicado: (2021)

Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications
por: Hochheuser, Caroline, et al.
Publicado: (2021)

TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis
por: Klamer, Sofieke E., et al.
Publicado: (2018)

Interferon-Gamma Impairs Maintenance and Alters Hematopoietic Support of Bone Marrow Mesenchymal Stromal Cells
por: Goedhart, Marieke, et al.
Publicado: (2018)

Nuclear shape, protrusive behaviour and in vivo retention of human bone marrow mesenchymal stromal cells is controlled by Lamin-A/C expression
por: Dorland, Yvonne L., et al.
Publicado: (2019)

Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel
por: van Wezel, Esther M., et al.
Publicado: (2019)

Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR
por: van Zogchel, Lieke M. J., et al.
Publicado: (2021)

Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential
por: Lak, Nathalie S. M., et al.
Publicado: (2023)

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma
por: van Zogchel, Lieke M. J., et al.
Publicado: (2020)

The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironment
por: Klamer, Sofieke, et al.
Publicado: (2014)

Extracellular Vesicles Derived From Adult and Fetal Bone Marrow Mesenchymal Stromal Cells Differentially Promote ex vivo Expansion of Hematopoietic Stem and Progenitor Cells
por: Ghebes, Corina A., et al.
Publicado: (2021)

Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients
por: Lobo, João, et al.
Publicado: (2021)

Impact of cholesterol on proinflammatory monocyte production by the bone marrow
por: Stiekema, Lotte C A, et al.
Publicado: (2021)

G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment
por: Martinez Sanz, Paula, et al.
Publicado: (2021)

Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease
por: Lak, Nathalie S.M., et al.
Publicado: (2021)

The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
por: Schoot, Reineke A., et al.
Publicado: (2013)

Metabolic crosstalk between stromal and malignant cells in the bone marrow niche
por: Tirado, Hernán A., et al.
Publicado: (2023)

Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
por: Bleeker, Gitta, et al.
Publicado: (2013)

Acute myeloid leukemia shapes the bone marrow stromal niche in vivo
por: Pievani, Alice, et al.
Publicado: (2020)

The metastatic niche and stromal progression
por: Sleeman, Jonathan P.
Publicado: (2012)

Hematopoietic stem and progenitor cells use podosomes to transcellularly cross the bone marrow endothelium
por: Rademakers, Timo, et al.
Publicado: (2020)

Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma
por: Cuperus, Roos, et al.
Publicado: (2009)

Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow Niche
por: Zeytin, Inci Cevher, et al.
Publicado: (2022)

A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies
por: Tomasoni, Chiara, et al.
Publicado: (2023)

Bone Marrow Environment in Metastatic Neuroblastoma
por: Brignole, Chiara, et al.
Publicado: (2021)

Bone Marrow Harbors a Unique Population of Dendritic Cells with the Potential to Boost Neutrophil Formation upon Exposure to Fungal Antigen
por: Goedhart, Marieke, et al.
Publicado: (2021)

Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors
por: van Zogchel, Lieke M. J., et al.
Publicado: (2021)

Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma
por: Lak, Nathalie S.M., et al.
Publicado: (2023)

Neuroblastoma and DIPG Organoid Coculture System for Personalized Assessment of Novel Anticancer Immunotherapies
por: M. Kholosy, Waleed, et al.
Publicado: (2021)

123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
por: Bleeker, Gitta, et al.
Publicado: (2015)

Inferring Gene Networks in Bone Marrow Hematopoietic Stem Cell-Supporting Stromal Niche Populations
por: Desterke, Christophe, et al.
Publicado: (2020)

Single‐cell transcriptomes of murine bone marrow stromal cells reveal niche‐associated heterogeneity
por: Addo, Richard K., et al.
Publicado: (2019)

Dynamic Changes of the Bone Marrow Niche: Mesenchymal Stromal Cells and Their Progeny During Aging and Leukemia
por: Woods, Kevin, et al.
Publicado: (2021)

Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors
por: van Zogchel, Lieke M. J., et al.
Publicado: (2023)

Treatment-Related Toxicities During Anti-GD2 Immunotherapy in High-Risk Neuroblastoma Patients
por: Blom, Thomas, et al.
Publicado: (2021)

Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics
por: van Gerven, Michael R., et al.
Publicado: (2022)

Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells
por: Nakata, Rie, et al.
Publicado: (2017)

Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al
por: Martinez Sanz, Paula, et al.
Publicado: (2021)

Fetal hematopoietic stem cell homing is controlled by VEGF regulating the integrity and oxidative status of the stromal-vascular bone marrow niches
por: Mesnieres, Marion, et al.
Publicado: (2021)

Mesenchymal stromal cells in the bone marrow niche consist of multi-populations with distinct transcriptional and epigenetic properties
por: Kanazawa, Sanshiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oevogrle3vi49ncqmjfl2uiamf